Oncology & Cancer

Oral chemo still too expensive even after doughnut hole closes

Access to expensive oral chemotherapy drugs will still be out of reach for millions of Americans with Medicare coverage, even when one of the most touted reforms in health care coverage takes place in 2020. The analysis, ...

Cardiology

Part D enrollment doesn't improve outcomes after AMI

(HealthDay)—For patients with acute myocardial infarction (AMI), enrollment in Part D by hospital discharge is not associated with improved outcomes, according to a study published online Oct. 27 in Circulation: Cardiovascular ...

Health

Reexamining the impact of Medicare Part D on health and savings

For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky ...

Cardiology

Full Rx coverage ups outcomes for patients discharged after MI

(HealthDay)—For patients discharged from hospital after myocardial infarction, full prescription coverage is associated with improved health outcomes and less resource use, according to research published online May 5 in ...

Arthritis & Rheumatism

Patients grapple with high cost of arthritis medications

The first national investigation of Medicare coverage of biologic disease modifying drugs (DMARDs) found that in starting a single biologic DMARD, patients face more than $2,700 in copayments each year before receiving relief ...

page 6 from 11